Answers are grounded in this paper and cite their sources.
Many promising drug candidates and pharmaceutical compounds fail due to idiosyncratic adverse drug reactions (IADRs), often arising from the formation of reactive metabolites. Among the "structural alerts" responsible, anilines are well-known to undergo deleterious metabolic processing, yet isosteric replacement strategies remain limited. Herein we discuss current art and potential new avenues of saturated isosteres to mitigate aniline-related toxicities.
No takes yet. Share an insight, caveat, or question.
Sodano et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: